District Court Orders Utah Company to Stop Distribution of Unapproved New Drugs and Adulterated Products | OPA | Department of Justice

The defendants agreed to settle the suit and be bound by a consent decree of permanent injunction. The consent decree requires, among other things, that the defendants stop manufacturing, processing, labeling, holding or distributing any drug, including products the defendants claim can treat or cure disease, until they comply with federal law. Defendants must either obtain FDA approval for all drug products or remove such drug claims from their labels, websites and other promotional materials. Source: District Court Orders Utah Company to Stop Distribution of Unapproved New Drugs and Adulterated Products | OPA | Department of Justice